A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
34 locations incl. Laguna Hills
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06943872·Phase 3·Recruiting